KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism-Reference-Cited by-同舟云学术

KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism

Published:2012-02 Issue:2 Volume:59 Page:235-240
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Mulatero Paolo¹,Tauber Philipp¹,Zennaro Maria-Christina¹,Monticone Silvia¹,Lang Katharina¹,Beuschlein Felix¹,Fischer Evelyn¹,Tizzani Davide¹,Pallauf Anna¹,Viola Andrea¹,Amar Laurence¹,Williams Tracy Ann¹,Strom Tim M.¹,Graf Elisabeth¹,Bandulik Sascha¹,Penton David¹,Plouin Pierre-François¹,Warth Richard¹,Allolio Bruno¹,Jeunemaitre Xavier¹,Veglio Franco¹,Reincke Martin¹

Affiliation:

1. From the Division of Internal Medicine and Hypertension (P.M., S.M., D.T., A.V., T.A.W., F.V.), University of Torino, Torino, Italy; Medical Cell Biology (P.T., S.B., D.P., R.W.), University Regensburg, Regensburg, Germany; Institut National de la Santé et de la Recherche Médicale (M.C.Z., L.A., P.F.P., X.J.), U970, Paris Cardiovascular Research Center, Paris, France; University Paris Descartes (M.C.Z., L.A., P.F.P., X.J.), Paris, France; Assistance Publique-Hôpitaux de Paris (M.C.Z., L.A., P.F.P.,...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference26 articles.

1. Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline

2. Diagnosis and treatment of primary aldosteronism

3. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

4. Cardiovascular and Cerebrovascular Comorbidities of Hypokalemic and Normokalemic Primary Aldosteronism: Results of the German Conn’s Registry

5. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KCNJ5 mutations in familial and non-familial primary aldosteronism;European Journal of Endocrinology;2024-05-23

2. Modulation of calcium signaling on demand to decipher the molecular mechanisms of primary aldosteronism;2024-05-02

3. Familial hyperaldosteronism: an European Reference Network on Rare Endocrine Conditions clinical practice guideline;European Journal of Endocrinology;2024-03-30

4. Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism;Endocrine;2024-03-06

5. Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism;Frontiers in Endocrinology;2024-03-01